Thus, the relative hyperinsulinemia observed in insulin-resistant individuals with obesity, T2DM, and prediabetes would favor accrual of bone mass, although the effect may be modified by the severity of insulin resistance and ambient adipocytokines (4–7, 27, 28). The gene discussed is INS; the disease is obesity due to melanocortin 4 receptor deficiency.